Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

etiprednol dicloacetate

Known as: ethyl-17alpha-dichloroacetoxy-11beta-hydroxyandrosta-1,4-diene-3-one-17beta-carboxylate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Loteprednol etabonate (LE) is the first, highly successful soft corticosteroid (SC) designed using the ‘inactive metabolite… Expand
Is this relevant?
2017
2017
Graphical abstract Figure. No Caption available. ABSTRACT The soft drug approach is successful in obtaining high local… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Review
2008
Review
2008
Despite its apparent easy accessibility, the eye is, in fact, well protected against the absorption of foreign materials… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2006
Review
2006
Inhaled and intranasal corticosteroids (ICSs) still are the most effective treatment available for allergic airway diseases and… Expand
Is this relevant?
2004
2004
In vitro and in vivo anti-inflammatory properties and soft characteristics of etiprednol dicloacetate (BNP-166) a new steroid… Expand
Is this relevant?
2004
2004
Etiprednol dicloacetate (ethyl 17alpha-dichloroacetoxy-11beta-hydroxy-androsta-1,4-diene-3-one-17beta-carboxylate, code-named… Expand
Is this relevant?
2004
2004
During development of chemistry of the soft drug candidate etiprednol dicloacetate (BNP-166) 1) optimization studies on the three… Expand
Is this relevant?
2003
2003
In the present study, the pharmacological effects of etiprednol dicloacetate (BNP-166; ethyl-17α-dichloroacetoxy-11… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
2003
2003
2003
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?